Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Health Technol Assess. 2016 Apr;20(35):1-610. doi: 10.3310/hta20350.
Health Technol Assess. 2016.
PMID: 27140438
Free PMC article.
Review.